These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10092950)
21. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme. Binevski PV; Sizova EA; Pozdnev VF; Kost OA FEBS Lett; 2003 Aug; 550(1-3):84-8. PubMed ID: 12935891 [TBL] [Abstract][Full Text] [Related]
23. Purification and characterisation of swine serum proteinase which hydrolyses epidermal inhibitory pentapeptide. Bramucci M; Miano A; Quassinti L; Maccari E; Canofeni S; Amici D Biochim Biophys Acta; 1996 Jun; 1290(2):184-90. PubMed ID: 8645722 [TBL] [Abstract][Full Text] [Related]
24. Measuring angiotensin-I converting enzyme inhibitory activity by micro plate assays: comparison using marine cryptides and tentative threshold determinations with captopril and losartan. Ben Henda Y; Labidi A; Arnaudin I; Bridiau N; Delatouche R; Maugard T; Piot JM; Sannier F; Thiéry V; Bordenave-Juchereau S J Agric Food Chem; 2013 Nov; 61(45):10685-90. PubMed ID: 24131339 [TBL] [Abstract][Full Text] [Related]
25. Modification of the furanacryloyl-L-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity. Murray BA; Walsh DJ; FitzGerald RJ J Biochem Biophys Methods; 2004 May; 59(2):127-37. PubMed ID: 15163524 [TBL] [Abstract][Full Text] [Related]
26. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I. Michaud A; Williams TA; Chauvet MT; Corvol P Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274 [TBL] [Abstract][Full Text] [Related]
27. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. Shalaby SM; Zakora M; Otte J J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177 [TBL] [Abstract][Full Text] [Related]
28. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor. Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart. Katwa LC; Ratajska A; Cleutjens JP; Sun Y; Zhou G; Lee SJ; Weber KT Cardiovasc Res; 1995 Jan; 29(1):57-64. PubMed ID: 7895240 [TBL] [Abstract][Full Text] [Related]
30. Isolation of angiotensin converting enzyme (ACE) binding protein from human serum with an ACE affinity column. Thevananther S; Brecher AS Can J Physiol Pharmacol; 1999 Mar; 77(3):216-23. PubMed ID: 10535696 [TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of a peptidyl dipeptidase resembling angiotensin converting enzyme from the electric organ of Torpedo marmorata. Turner AJ; Hryszko J; Hooper NM; Dowdall MJ J Neurochem; 1987 Mar; 48(3):910-6. PubMed ID: 3027262 [TBL] [Abstract][Full Text] [Related]
32. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction. van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077 [TBL] [Abstract][Full Text] [Related]
33. Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex. Oshima G; Hiraga Y; Shirono K; Oh-ishi S; Sakakibara S; Kinoshita T Experientia; 1985 Mar; 41(3):325-8. PubMed ID: 2982643 [TBL] [Abstract][Full Text] [Related]
34. [Properties and action specificity of carboxycathepsin (peptidyl dipepsidase) from bovine kidneys]. Eliseeva IuE; Orekhovich VN; Pavlikhina LV Vopr Med Khim; 1976; 22(1):81-9. PubMed ID: 193290 [TBL] [Abstract][Full Text] [Related]
35. Mixed-type inhibition of bovine lung angiotensin converting enzyme by lisinopril and its dansyl derivative. Uçar G; Ozer I Biochem Pharmacol; 1992 Aug; 44(3):565-70. PubMed ID: 1324678 [TBL] [Abstract][Full Text] [Related]
36. The endopeptidase activity and the activation by Cl- of angiotensin-converting enzyme is evolutionarily conserved: purification and properties of an an angiotensin-converting enzyme from the housefly, Musca domestica. Lamango NS; Sajid M; Isaac RE Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):639-46. PubMed ID: 8670080 [TBL] [Abstract][Full Text] [Related]
37. Purification of angiotensin I-converting enzyme from human lung. Nishimura K; Yoshida N; Hiwada K; Ueda E; Kokubu T Biochim Biophys Acta; 1977 Aug; 483(2):398-408. PubMed ID: 19071 [TBL] [Abstract][Full Text] [Related]
38. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions. Brooks RR; Miller KE; Jones SM; Burns RH; Huang CT J Pharm Sci; 1990 May; 79(5):384-8. PubMed ID: 2161922 [TBL] [Abstract][Full Text] [Related]
39. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits. Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422 [TBL] [Abstract][Full Text] [Related]
40. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]